Skip to main content

Modelling the pharmacological screening: controlling the processes and the chemical, biological and experimental information

  • Chapter
  • First Online:
Chemogenomics and Chemical Genetics
  • 1189 Accesses

Abstract

Why undertake modelling of the screening process? Although the screening of bioactive molecules does not always fall into the category of being high-throughput (‘only’ several tens of thousands of molecules screened at a time in pharmacological screens within academic laboratories), the quantity of data generated is significant. Does one wish to save the raw results and the parameters of these experiments? On the scale of a single screen, the analysis of the raw data and the identification of potential hits can potentially be carried out with the help of a simple spreadsheet (the most popular being supplied as part of office software along with word processing programs). Such a ‘manual’ solution is already more difficult to establish when the user wishes to understand particular results by correlating them with different parameters such as the molecular structures or the experimental conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • FOWLER M. (2001) UML. Le Tout en Poche, Campus Press, Paris

    Google Scholar 

  • LARMAN C. (2002) UML et les Design Patterns. Campus Press, Paris

    Google Scholar 

  • MORGAT A. and RECHENMANN F. (2002) Bio-informatique. Modélisation des données biologiques. Médecine Sciences 18: 366-374

    Article  Google Scholar 

  • MULLER P.A. and GAERTNER N. (2000) Modélisation objet avec UML. Eyrolles, Paris

    Google Scholar 

  • NAIBURG E. and MAKSIMCHUK R. (2002) Bases de données avec UML. Campus Press, Paris

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Roy, S. (2011). Modelling the pharmacological screening: controlling the processes and the chemical, biological and experimental information. In: MARECHAL, E., Roy, S., Lafanechère, L. (eds) Chemogenomics and Chemical Genetics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19615-7_6

Download citation

Publish with us

Policies and ethics